Ren Minghui's research while affiliated with National Health and Family Planning Commission for the PRC and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (4)
Bernard Pécoul and colleagues call for the establishment of a global biomedical R&D fund as a key priority of the G7 summit in June 2015.
Citations
... 19 There are also demands for truly needs-driven R&D that delivers adequate health technologies for unmet or new medical needs, such as antimicrobial resistance and emerging infectious diseases (including Ebola, Zika, and COVID-19). 20 In recent years, we have also begun seeing instances of pharmaceutical companies choosing to not register or sell their product in some countries because doing so is not financially attractive enough, despite clear medical needs and demand for the product. 21 This supply control by companies over where to make products available has become a daily reality with COVID-19 vaccines and other medical technologies needed for pandemic control. ...
... Third, the country has both benefited from, and contributed to, global health cooperation on malaria elimination. As in other areas, China has leveraged collaborations with external agencies, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, to actively develop its domestic systems and capacities [8]. However, as China's domestic malaria elimination efforts has progressed, so has global health collaboration, initially with neighboring countries in Southeast Asia and subsequently with some countries from Africa. ...
... China has always been a strong advocate and practitioner of global health, and has demonstrated a firm commitment to its improvement [1]. One of the aims of China's "Belt and Road Initiative" was to improve the health of the populations of the countries alongside [2]. ...
... Moreover, the BRICS countries plan to launch a communicable disease surveillance system to share epidemic data and information to prevent pandemics and control outbreaks in a better way. BRICS built the BRICS Vaccine Research Centre in 2021 and committed to delivering vaccines as a global public good and increasing equity in access [49]. The BRICS countries also established the BRICS Committee for International Cooperation in Health (BCICH), which aims to promote academic exchanges in the field of traditional medicine among medical personnel from BRICS countries [50]. ...